Literature DB >> 1116890

Associations between oral clefts and drugs taken during pregnancy.

I Saxén.   

Abstract

Associations between drug consumption during pregnancy and the birth of children with oral clefts were studied in material from the Finnish Register of Congenital Malformations, consisting of 599 children with clefts and their matched controls. Information concerning maternal drug consumption was partly prospective. During the first trimester, analgesic, chemotherapeutic and antineurotic drugs had all been significantly more frequently used by the mothers of children with clefts, than by the control mothers. The consumption of drugs was in general more frequent among mothers of children with cleft lip, with or without cleft palate, than among those of children with cleft palate alone.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1116890     DOI: 10.1093/ije/4.1.37

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  30 in total

Review 1.  Regulated formation of eicosanoids.

Authors:  F A Fitzpatrick; R Soberman
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 2.  Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis.

Authors:  Rami Jean Salib; Peter Hugo Howarth
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

3.  The teratogenic effects of 5-fluoro-2-desoxyuridine (F.U.D.R.) on the Wistar rat fetus with particular reference to cleft palate.

Authors:  M W Ferguson
Journal:  J Anat       Date:  1978-05       Impact factor: 2.610

4.  The use of central nervous system active drugs during pregnancy.

Authors:  Bengt Källén; Natalia Borg; Margareta Reis
Journal:  Pharmaceuticals (Basel)       Date:  2013-10-10

Review 5.  The safety of antimalarial drugs in pregnancy.

Authors:  P A Phillips-Howard; D Wood
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

6.  Prenatally buprenorphine-exposed children: health to 3 years of age.

Authors:  Kaisa Kivistö; Sarimari Tupola; Satu Kivitie-Kallio
Journal:  Eur J Pediatr       Date:  2015-05-24       Impact factor: 3.183

7.  Teratogenic Effects of `Recreational' Drugs: Increasing the risk of congenital anomalies.

Authors:  J E Polifka; J M Friedman
Journal:  Can Fam Physician       Date:  1991-09       Impact factor: 3.275

8.  Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States.

Authors:  Brian T Bateman; Sonia Hernandez-Diaz; James P Rathmell; John D Seeger; Michael Doherty; Michael A Fischer; Krista F Huybrechts
Journal:  Anesthesiology       Date:  2014-05       Impact factor: 7.892

Review 9.  Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review.

Authors:  Jennifer N Lind; Julia D Interrante; Elizabeth C Ailes; Suzanne M Gilboa; Sara Khan; Meghan T Frey; April L Dawson; Margaret A Honein; Nicole F Dowling; Hilda Razzaghi; Andreea A Creanga; Cheryl S Broussard
Journal:  Pediatrics       Date:  2017-06       Impact factor: 7.124

Review 10.  Medical and psychological risks and consequences of long-term opioid therapy in women.

Authors:  Beth D Darnall; Brett R Stacey; Roger Chou
Journal:  Pain Med       Date:  2012-08-20       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.